Digital health interventions (DHIs) show promise for the treatment of mental health disorders. However, existing meta-analytical research is methodologically heterogeneous, with studies including a ...

A new update, led by researchers at the UNC School of Medicine and the Gillings School of Global Public Health, describes ...

Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as ...

Elizabeth Haase, MD, former chair of the American Psychiatric Association's Committee on Climate Change, shared her advice ...

Nearly 150 new Florida laws went into effect July 1 and some of them make big changes you need to know. Here's the list.

A herbal mouthwash selectively killed off bad bacteria in the mouth while preserving the good strains, according to a new ...

Nearly 150 laws went into effect in Florida on July 1, including a wide variety of new crimes, harsher penalties, and changes ...

Shenzhen Bay Laboratory has synthesized G protein-coupled receptor GPR139 agonists reported to be useful for the treatment of Parkinson’s disease, epilepsy, pain, depression, schizophrenia, substance ...

A team of researchers at NYU Abu Dhabi has uncovered a key mechanism that helps shape how our brains are wired, and what can ...

Some research suggests that omega-3 supplements may have specific benefits for people with schizophrenia. Most studies point to a specific type of omega-3 fatty acid known as eicosapentaenoic acid ...

Researchers have uncovered how losing the autism-linked gene PTEN in a specific set of inhibitory neurons reshapes brain circuits tied to fear and anxiety.

Boehringer Ingelheim has taken an option on a family of GPR52 agonist compounds with potential in schizophrenia from Sosei Heptares, in a €755m deal.